Hongo Hiroshi

Affiliation and department：

Research field (1)： Urology

Research theme for competitive and other funds (5)：

2021 - 2024 抗癌剤耐性前立腺癌のゲノム不安定性の解析と合成致死を利用した新規治療戦略
2020 - 2022 Reprogramming of cell polarity in refractory prostate cancer
2017 - 2020 Search for biomarkers and novel therapeutic strategies targeting heterogeneity and plasticity in prostate cancer
2017 - 2019 Novel treatment strategy for refractory prostate cancer targeting EMT related genes
2015 - 2017 New treatment strategy of refractory prostate cancer by targeting interdependent signaling pathways.

Papers (88)：

Hiroshi Hongo, Takeo Kosaka, Ken-Ichi Takayama, Yuto Baba, Yota Yasumizu, Koji Ueda, Yutaka Suzuki, Satoshi Inoue, Himisha Beltran, Mototsugu Oya. G-protein signaling of oxytocin receptor as a potential target for cabazitaxel-resistant prostate cancer. PNAS nexus. 2024. 3. 1. pgae002
Daiki Yamamoto, Hiroshi Hongo, Takeo Kosaka, Natsumi Aoki, Mototsugu Oya, Toshinori Sato. The sialyl-Tn antigen synthase genes regulates migration-proliferation dichotomy in prostate cancer cells under hypoxia. Glycoconjugate journal. 2023. 40. 2. 199-212
Tomohiro Iwasawa, Takeo Kosaka, Yota Yasumizu, Hiroshi Hongo, Yoshinori Yanai, Yuto Baba, Kazuhiro Matsumoto, Kohei Nakamura, Hiroshi Nishihara, Mototsugu Oya. Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series. International Journal of Clinical Oncology. 2022. 27. 12. 1867-1873
Hiroshi Hongo, Takeo Kosaka, Kohei Nakamura, Shuji Mikami, Hiroshi Nishihara, Mototsugu Oya. The first Japanese case of intraductal cancer of the prostate with checkpoint kinase 2 mutation. Asian Journal of Urology. 2022. 9. 4. 480-482
Takahiro Komori, Takeo Kosaka, Keitaro Watanabe, Tomoki Tanaka, Yota Yasumizu, Hiroshi Hongo, Shuji Mikami, Toshio Ohashi, Mototsugu Oya. Salvage focal brachytherapy in castration-resistant prostate cancer with neuroendocrine differentiation after radiation therapy. IJU Case Reports. 2022. 5. 4. 233-236

ｍore...

MISC (46)：

Hiroshi Hongo, Takeo Kosaka, Yasumasa Miyazaki, Nobuyuki Tanaka, Mototsugu Oya. In silico screening for identification of novel drugs for overcoming taxane-resistant prostate cancer. CANCER SCIENCE. 2021. 112. 916-916
Takeo Kosaka, Hiroshi Hongo, Yota Yasumizu, Kazuhiro Matshumoto, Ryuichi Mizuno, Mototsugu Oya. The prognostic biomarkers of the patients treated with platinum-based chemotherapy in treatment emergent or related neuroendocrine prostate cancer. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
Hiroshi Hongo, Takeo Kosaka, Yota Yasumizu, Nobuyuki Tanaka, Toshikazu Takeda, Kazuhiro Matsumoto, Ryuichi Mizuno, Mototsugu Oya. IN SILICO SCREENING FOR IDENTIFICATION OF NOVEL DRUGS FOR OVERCOMING CABAZITAXEL-RESISTANT PROSTATE CANCER. JOURNAL OF UROLOGY. 2020. 203. E215-E215
Hiroshi Hongo, Takeo Kosaka, Yoshinori Yanai, Yota Yasumizu, Nobuyuki Tanaka, Toshikazu Takeda, Kazuhiro Matsumoto, Ryuichi Mizuno, Mototsugu Oya. OVERCOMING CABAZITAXEL RESISTANCE BY G2/M REGULATING GENES IN CASTRATION-RESISTANT PROSTATE CANCER. JOURNAL OF UROLOGY. 2020. 203. E214-E214
Takeo Kosaka, Hiroshi Hongo, Koji Ueda, Mototsugu Oya. IN SILICO SCREENING TARGETING THE REPROGRAMMING OF LINEAGE PLASTICITY IN NEUROENDOCRINE PROSTATE CANCER. JOURNAL OF UROLOGY. 2020. 203. E561-E562

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page